A new clinical trial of a drug which could help slow down the progression of early Alzheimer’s disease is underway at Foss Park Hospital in York.
Morning Overview on MSN
Study links reduced visual sensitivity to dementia risk up to 12 years early
Researchers at Loughborough University have found that reduced visual processing speed can flag dementia risk as many as 12 ...
Denali Therapeutics said Takeda Pharmaceuticals terminated the companies' agreement to co-develop and commercialize a dementia drug. Denali would regain full ownership of DNL593, an investigational ...
New research has found that eating more meat could help prevent Alzheimer's in some people who carry a gene that heightens ...
Denali plans to continue clinical development of DNL593, which is designed to deliver progranulin to the brain using TransportVehicle™ technologyResults from ongoing Phase 1/2 study in patients with ...
The motor components of juggling are fairly simple,” says Professor Tommy Wood, while steering apples through the air, “once ...
Never has such a wealth of information been at your fingertips to explain your symptoms or summon deepfakes to sell you on ...
Morning Overview on MSN
Higher midlife vitamin D tied to lower tau biomarker years later
People who maintain adequate vitamin D levels in their late 30s may carry less tau protein in their brains more than a decade ...
EXCLUSIVE: Chris Bane is supporting Alzheimer's Research UK's call for the impact of dementia on carers to be fully ...
A new study suggests that vitamin D levels in midlife may influence brain health years later. However, experts say the ...
Scientists are beginning to understand that the same diet may not work the same way for everyone. A new study from Karolinska ...
Older adults who receive a high-strength flu shot may be linked to a lower risk of developing Alzheimer's disease, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results